Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Multiple benefits from dual release hydrocortisone: a "hard" view from bones.

Literature DB >> 29774503

Multiple benefits from dual release hydrocortisone: a "hard" view from bones.

D A Vassiliadi¹, S Tsagarakis².

Abstract

Entities: Chemical

Mesh：

Substances：
Hydrocortisone

Year: 2018 PMID： 29774503 DOI： 10.1007/s12020-018-1628-y

Source DB: PubMed Journal: Endocrine ISSN： 1355-008X Impact factor: 3.633

× No keyword cloud information.

12 in total

1. The history of the discovery of Addison's disease.

Authors: P M F BISHOP
Journal: Proc R Soc Med Date: 1950-01

Review 2. MANAGEMENT OF ENDOCRINE DISEASE: Risk of overtreatment in patients with adrenal insufficiency: current and emerging aspects.

Authors: G Mazziotti; A M Formenti; S Frara; E Roca; P Mortini; A Berruti; A Giustina
Journal: Eur J Endocrinol Date: 2017-06-05 Impact factor: 6.664

3. Pharmacokinetic evidence for suboptimal treatment of adrenal insufficiency with currently available hydrocortisone tablets.

Authors: Nicolas Simon; Frederic Castinetti; Floriane Ouliac; Nathalie Lesavre; Thierry Brue; Charles Oliver
Journal: Clin Pharmacokinet Date: 2010-07 Impact factor: 6.447

Review 4. Adrenal insufficiency: review of clinical outcomes with current glucocorticoid replacement therapy.

Authors: Gudmundur Johannsson; Alberto Falorni; Stanko Skrtic; Hans Lennernäs; Marcus Quinkler; John P Monson; Paul M Stewart
Journal: Clin Endocrinol (Oxf) Date: 2014-10-10 Impact factor: 3.478

5. Bone safety of dual-release hydrocortisone in patients with hypopituitarism.

Authors: Stefano Frara; Sabrina Chiloiro; Teresa Porcelli; Antonella Giampietro; Gherardo Mazziotti; Laura De Marinis; Andrea Giustina
Journal: Endocrine Date: 2018-01-08 Impact factor: 3.633

6. Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation.

Authors: G Johannsson; A G Nilsson; R Bergthorsdottir; P Burman; P Dahlqvist; B Ekman; B E Engström; T Olsson; O Ragnarsson; M Ryberg; J Wahlberg; B M K Biller; J P Monson; P M Stewart; H Lennernäs; S Skrtic
Journal: J Clin Endocrinol Metab Date: 2011-11-23 Impact factor: 5.958

7. High Evening Cortisol Level Is Associated With Low TBS and Increased Prevalent Vertebral Fractures: OsteoLaus Study.

Authors: Elena Gonzalez Rodriguez; Olivier Lamy; Delphine Stoll; Marie Metzger; Martin Preisig; Christine Kuehner; Peter Vollenweider; Pedro Marques-Vidal; Gérard Waeber; Bérengère Aubry-Rozier; Didier Hans
Journal: J Clin Endocrinol Metab Date: 2017-07-01 Impact factor: 5.958

8. Vertebral fractures assessed with dual-energy X-ray absorptiometry in patients with Addison's disease on glucocorticoid and mineralocorticoid replacement therapy.

Authors: Valentina Camozzi; Corrado Betterle; Anna Chiara Frigo; Veronica Zaccariotto; Martina Zaninotto; Erica De Caneva; Paola Lucato; Walter Gomiero; Silvia Garelli; Chiara Sabbadin; Monica Salvà; Miriam Dalla Costa; Marco Boscaro; Giovanni Luisetto
Journal: Endocrine Date: 2017-08-09 Impact factor: 3.633